Hebert, A., Schrieber, R., Glaab, D., & Eichenfield, L. (2020). Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 4(6), s77. https://doi.org/10.25251/skin.4.supp.77